ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Acasti Pharma Inc

Acasti Pharma Inc (ACST)

0.58
0.00
(0.00%)
Closed January 21 3:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.58
Bid
0.58
Ask
0.98
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.58
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
9,399,000
Dividend Yield
-
PE Ratio
-2.46
Earnings Per Share (EPS)
-1.37
Revenue
-
Net Profit
-12.85M

About Acasti Pharma Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Jersey City, New Jersey, USA
Founded
-
Acasti Pharma Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker ACST. The last closing price for Acasti Pharma was $0.58. Over the last year, Acasti Pharma shares have traded in a share price range of $ 0.00 to $ 0.00.

Acasti Pharma currently has 9,399,000 shares outstanding. The market capitalization of Acasti Pharma is $5.45 million. Acasti Pharma has a price to earnings ratio (PE ratio) of -2.46.

ACST Latest News

Acasti Pharma Reports Third Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule

LAVAL, Québec, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31

LAVAL, Québec, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18

LAVAL, Québec, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures

LAVAL, Québec, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia

LAVAL, Québec, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN)

LAVAL, Québec, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti Pharma Reports Second Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

Acasti Pharma to Present at Q4 Investor Summit

LAVAL, Québec, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022

LAVAL, Quebec, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ACST - Frequently Asked Questions (FAQ)

What is the current Acasti Pharma share price?
The current share price of Acasti Pharma is $ 0.58
How many Acasti Pharma shares are in issue?
Acasti Pharma has 9,399,000 shares in issue
What is the market cap of Acasti Pharma?
The market capitalisation of Acasti Pharma is CAD 5.45M
What is the 1 year trading range for Acasti Pharma share price?
Acasti Pharma has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Acasti Pharma?
The price to earnings ratio of Acasti Pharma is -2.46
What is the reporting currency for Acasti Pharma?
Acasti Pharma reports financial results in USD
What is the latest annual profit for Acasti Pharma?
The latest annual profit of Acasti Pharma is USD -12.85M
What is the registered address of Acasti Pharma?
The registered address for Acasti Pharma is 103 CARNEGIE CENTER, SUITE 300 PRINCETON, JERSEY CITY, NEW JERSEY, 08540
What is the Acasti Pharma website address?
The website address for Acasti Pharma is www.acastipharma.com
Which industry sector does Acasti Pharma operate in?
Acasti Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ASTAstron Connect Inc
$ 0.09
(200.00%)
11.19k
MPTH.HMapath Capital Corp
$ 0.035
(133.33%)
1,000
MVYMoovly Media Inc
$ 0.01
(100.00%)
163.93k
MTN.HMartina Minerals Corp
$ 0.05
(100.00%)
5k
SOP.HSoperior Fertilizer Corp
$ 0.01
(100.00%)
27.82k
NICKNickelex Resource Corporation
$ 0.005
(-50.00%)
10k
GNFIGenifi Inc
$ 0.005
(-50.00%)
12k
CANDCandelaria Mining Corp
$ 0.005
(-50.00%)
147.95k
ENTGEntourage Health Corp
$ 0.005
(-50.00%)
43.5k
TVC.HThree Valley Copper Corp
$ 0.005
(-50.00%)
3.31k
CPLCopper Lake Resources Ltd
$ 0.01
(0.00%)
6.46M
SICSokoman Minerals Corporation
$ 0.06
(50.00%)
4.93M
THRMTherma Bright Inc
$ 0.05
(25.00%)
4.88M
NDANeptune Digital Assets Corp
$ 1.65
(23.13%)
4.14M
TUKTuktu Resources Ltd
$ 0.145
(16.00%)
3.28M

Discussion

View Full Feed
BDEZ BDEZ 2 minutes ago
Not even one government building was found to be even half occupied...insane

Trump signed an Executive Order directing all federal employees to return to full time in person work

https://x.com/elonmusk/status/1881703511806881988
BDEZ BDEZ 4 minutes ago
47 signed an executive order rescinding Lyndon Johnson's EO 11246, which established affirmative action, and banning all federal contractors and publicly-funded universities from practicing race-based discrimination, including DEI.

A massive shift

https://x.com/realchri
BDEZ BDEZ 5 minutes ago
Lyndon Johnson established affirmative action? Didn't know that....what a disaster he was.
bwrbad bwrbad 5 minutes ago
promised to accumulate 10k shares before Q end and hold for years. predict this issue never go BK, do RS, and one day go beyond 200+ like established big cap security issues.
RXRX
BDEZ BDEZ 9 minutes ago
Antifa launches attack on Portland ICE detention center

https://x.com/JackPosobiec/status/1881917911419547965
mrfence mrfence 10 minutes ago
Be sure to set an alert for when Pelosi starts buying our twins.
FMCC
SkyLimit2022 SkyLimit2022 12 minutes ago
zero82,

https://investorshub.advfn.com/uimage/uploads/2025/1/22/fyobygiphy.gif

Since you seem more than willing to generously dispense free pearls of wisdom and psychic predictions here on this board, tell us all what you think PD1 drugs will be worth in 2025, 2030 and
NWBO
Biotechotcguy Biotechotcguy 13 minutes ago
OMO based on the last 10Q don't they only have enough cash to last them through the year? You suspecting they're out there raising more ?
DROR
fuagf fuagf 13 minutes ago
Like just then i revisited my reply to you, and mail is empty. I got two mail notifications. Mail still empty.

Forget it, just felt like telling you. ;-)
TightCoil TightCoil 14 minutes ago
What is the stock price prediction for FNMA?
A break-up at the top trend line at $7.22 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 97.37% during the next 3 months and, with a 90% probability hold a price between $6.43 and
FNMA
OMOLIVES OMOLIVES 16 minutes ago
?.... and what in the fk' does that have to do with Aug 23rd, 2024? Seriously. I am not playing this stupid game EOM
HMBL
Truenorth2016 Truenorth2016 18 minutes ago
Quantum Computing New Era In Tech Begins!!! This is Todays News Folks!!! LOLOL...Cant make This Up!!! Quantum Stock Ran Big Today Right After Trump Inauguration First Day and More To Come!!! Quantum Stocks Going To Run Big Under Trump Administration. Trump gave us the hint when he had all those Tec
GCAN
Nebuchadnezzar Nebuchadnezzar 19 minutes ago
REG D filing $180,000,0000

13. Offering and Sales Amounts

Total Offering Amount $ 180,000,000 USD

Total Amount Sold $ 180,000,000 USD

Total Remaining to be Sold $ 0 USD

https://www.otcmarkets.com/stock/RITE/disclosure
RITE
Richie R Richie R 19 minutes ago
Ok, wake up...
930 930 19 minutes ago
What will Wednesday bring us?
KULR
gitreal gitreal 23 minutes ago
Hopefully whoever filed this FOIA will receive the emails and find some interesting information on AABB. Even better would be someone at the SEC starting an investigation and ordering a deposition, in person, by AABB "management". And former management. Or, digging into bank records....that would
AABB
Truenorth2016 Truenorth2016 24 minutes ago
We Havent Had a TSN*P In 3 years. Like I said previosly it takes years to get that breakout OTC play that runs over a dollar from 000's. GCAN just might be that play. It is time! GCAN PR said they plan on covering two of the hottest sectors in Tech, Quantum Computing and AI. Cant afford to sleep on
GCAN
elks elks 25 minutes ago
Tic toc. Happy birthday George. Lfg.
GVSI
want2retire want2retire 26 minutes ago
Oddly is appears you "forgot" to list the pros side of the pros and cons.  You know, the way any reasonable person usually contemplates things.

Now why would anyone want to only highlight the cons?  Hmmmm.....

;-)
KBLB
Kool Aid Man Kool Aid Man 28 minutes ago
Ask Nate..he said he met with Hoon Chang and Alcala in Nov 18-21 2023 in Atlanta.

https://www.otcmarkets.com/filing/html?id=17255367&guid=pg0-kK29eJ15h3h
SPZI
axelvento axelvento 28 minutes ago
Larry Ellison of Oracle: AI will design mRNA vaccines for every individual person against cancer — making them robotically in 48 hours.

"This is the promise of AI."



In a White House briefing on Tuesday, President Donald Trump unveiled the Stargate Projec
MRNA
StockItOut StockItOut 28 minutes ago
kill a cop have your felony buddy get you out. Deranged ain't me.
XERI

Your Recent History

Delayed Upgrade Clock